CanCog Technologies hires Dr. David Stevens as Executive Chairman of the Board

We are pleased to announce that Dave Stevens, DVM Ph.D.,has agreed to join CanCog Technologies Inc. in the capacity of Executive Chairman of the Board. Dr. Stevens brings essential experience in both the human and animal pharmaceutical industry, having previously served as CEO of Deprenyl Animal Health, which developed Anipryl, the first FDA sanctioned drug for an AD-like disease in geriatric dogs.